FDA Inspection
Biom Pharmaceutical CorporationBiom Pharmaceutical Corporation – FDA Inspection, Mar 10, 2022
Record Details
This FDA Inspection record concerns Biom Pharmaceutical Corporation, with an inspection on March 10, 2022, issued by the Center for Food Safety and Applied Nutrition, covering food/cosmetics.
- Inspection Date
- March 10, 2022
- Product Type
- Food/cosmetics
View Company Profile
ID · 22782b66-e07b-410b-9773-5249ae2851b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1164143
- FDA center
- Foods & Cosmetics
- Project area
- Food Composition, Standards, Labeling and Econ
FDA Citations
9- 21 CFR 111.83(a)Reserve sample - collect, hold
- 21 CFR 111.70(b)(1)Specifications - component identity
- 21 CFR 111.70(b)(2)Specifications-component purity, strength, composition
- 21 CFR 111.70(e)Specifications - identity, purity, strength, composition
- 21 CFR 111.403Written procedures - labeling operations
- 21 CFR 111.403Written procedures -packaging operations
- 21 CFR 111.180(b)(2)Records - receiving; components, packaging, labels, products
- 21 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
- 21 CFR 111.255(b)Batch record - complete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biom Pharmaceutical Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | VAI | Florida District Office | Food Composition, Standards, Labeling, and Economics |
Other documents for Biom Pharmaceutical Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.